**Tom Holland’s Oscar prospects for the 2027 ceremony remain slim, with traders pricing “No” at 86.5% due to limited awards momentum for his supporting turn as Telemachus in Christopher Nolan’s *The Odyssey*.** While the film dominates Best Picture and craft predictions with strong box-office results and critical acclaim, Holland’s role has not generated the precursor buzz, guild attention, or critic-circle traction needed for a Supporting Actor nod. Recent industry trackers (Variety, Gold Derby, Awards Daily) list frontrunners such as John Malkovich (*Wild Horse Nine*), Andrew Scott (*Elsinore*), Matt Damon (*The Odyssey*), and others, with no sustained placement for Holland. Superhero or franchise performances have historically faced steep barriers in acting categories absent exceptional dramatic showcases, and *Spider-Man: Brand New Day*’s commercial success has not translated into awards positioning for him. Key upcoming catalysts include guild nominations (SAG-AFTRA, PGA) and critics’ awards in late 2026/early 2027, but the absence of early campaign signals or standout reviews for his performance reinforces the market consensus. Entertainment outcomes can shift with late reviews or unexpected guild recognition, yet current verified developments show no pathway strong enough to challenge the heavy “No” pricing.